NCT07127822 2025-08-17
Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer
Peking University
Phase 2 Not yet recruiting
Clinical Trials
1 trialsNot yet recruiting × Gastric / Gastroesophageal Junction Adenocarcinoma × Other solid neoplasm × Clear all